Drug Shortage Report for KETALAR
Report ID | 131448 |
Drug Identification Number | 00224405 |
Brand name | KETALAR |
Common or Proper name | KETALAR |
Company Name | ERFA CANADA 2012 INC |
Market Status | MARKETED |
Active Ingredient(s) | KETAMINE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10ML VIAL |
ATC code | N01AX |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-01-01 |
Actual start date | 2021-01-04 |
Estimated end date | 2021-01-29 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-01-12 |
Company comments | |
Health Canada comments | |
Contact Address | 8250 BLVD DECARIE, SUITE 110 MONTREAL, QUEBEC CANADA H4P 2P5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v3 | 2021-01-12 | French | Compare |
v2 | 2021-01-12 | English | Compare |
v1 | 2021-01-12 | English | Compare |